🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Recruitingn/aAges 18 Years - 69 YearsAllAsfendiyarov Kazakh National Medical University
NCT06953180 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 to 69 years. * Residents of 17 regions of Kazakhstan. * Willingness to participate and provide informed consent. Exclusion Criteria: * Age less than 18 years old or over 69 years old. * Failure to provide informed consent or incomplete participation in data collection procedures.
💊

What it tests

  • Genetic: DNA analysis
📍

Where

1 site
Asfendiyarov Kazakh National Medical University
Almaty, Kazakhstan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy